--- title: OpenAI, Healthcare, and the Limits of Access date: 2026-04-28T06:13:37Z modified: 2026-08-01T09:03:30Z permalink: "https://www.micheledpierri.com/2026/04/28/openai-healthcare-and-the-limits-of-access/" type: post status: publish excerpt: "" wpid: 2682 categories: - Health Informatics featured_image: "https://www.micheledpierri.com/wp-content/uploads/2026/04/GPTHeatlh.png" featured_image_alt: A doctor tries to open a door to extraordinary tools. timestamp: 2026-08-01T09:03:30Z tags: - Health Informatics --- # ChatGPT for Clinicians: A First Look from Italy _Article authored by Michele D. Pierri, MD_ _Cardiac Surgeon & Medical Technology Researcher_ _L_ast checked: April 28, 2026__ _Reading time: 7 minutes_ --- OpenAI has rolled out a set of healthcare-oriented products built around ChatGPT. The headline reads, at first, like the launch of a single “medical GPT” available to physicians everywhere. The actual picture is more layered. What OpenAI is building is not one universal medical chatbot, but a differentiated healthcare ecosystem with distinct products for individual clinicians, healthcare organizations, and patients. For individual physicians, the relevant product is **ChatGPT for Clinicians**. OpenAI describes it as a version of ChatGPT engineered to support clinical tasks: documentation, medical research, evidence review, clinical reasoning. The product was announced on April 22, 2026. Access, at present, is free for verified individual clinicians in the United States. Eligible users include physicians, nurse practitioners, physician assistants, and pharmacists. ![](https://www.micheledpierri.com/wp-content/uploads/2026/04/Screenshot-2026-04-28-075826-1024x513.png) Worth pausing here. ChatGPT for Clinicians includes access to advanced AI models for complex clinical questions, reusable clinical workflows organized as “skills,” trusted clinical search with citations, deep research across medical journals, and (in eligible situations) support for continuing medical education credits. OpenAI states that conversations within ChatGPT for Clinicians are not used to train its models. Optional HIPAA support may be available through a Business Associate Agreement for eligible accounts. On one point OpenAI is explicit: ChatGPT for Clinicians is meant to support clinicians, not replace clinical judgment. The distinction is not cosmetic. A clinical AI assistant can retrieve evidence, summarize literature, draft documents, and structure reasoning. It cannot assume professional responsibility for diagnosis, treatment, informed consent, or patient safety. ## The practical problem: access is currently U.S.-centered For a physician practicing in Italy, the limiting factor surfaces almost immediately. According to OpenAI’s official documentation, signing up for ChatGPT for Clinicians requires a ChatGPT account, a valid **National Provider Identifier**, and a license verifiable through a third-party provider. ![](https://www.micheledpierri.com/wp-content/uploads/2026/04/Screenshot-2026-04-28-080221.png) The National Provider Identifier (NPI) is a U.S. healthcare identifier. The Centers for Medicare & Medicaid Services define it as a unique 10-digit number used to identify healthcare providers in HIPAA standard transactions. The result is a concrete barrier. An Italian physician registered with the Italian medical licensing system does not normally hold a U.S. NPI. The current self-service access route to ChatGPT for Clinicians is therefore not just difficult for a physician working in Italy. It is essentially not applicable. A bit of a let-down. Not because verification itself is unreasonable, of course. Quite the opposite: healthcare AI tools should require strict professional verification, regulatory safeguards, and clear accountability. The disappointment lies elsewhere. The first access route is built almost entirely around U.S. healthcare infrastructure. For clinicians outside the United States, including those of us working within European systems, the announcement reads as both exciting and frustrating. The product exists. The door is not yet really open. OpenAI does mention plans to expand access to additional countries over time, with pilots for verified clinicians outside the United States in collaboration with the Better Evidence Network, where local regulations permit. As things stand at the time of writing, however, the individual access pathway remains U.S.-based. ## ChatGPT for Healthcare: the institutional route Separate from the clinician product is **ChatGPT for Healthcare**. This one is not primarily a self-service tool for individual doctors. It is an enterprise version of ChatGPT designed for healthcare organizations: clinicians, administrators, researchers. OpenAI describes it as a secure workspace with enterprise-grade governance, compliance controls, clinical search, centralized administration, and HIPAA support. The distinction matters. **ChatGPT for Clinicians** targets individual verified clinicians in the United States. **ChatGPT for Healthcare** targets healthcare organizations that need scaled deployment, administrative controls, institutional data connections, and security governance. For European hospitals, universities, or research centers, ChatGPT for Healthcare may eventually become the more realistic route. Eventually. In Europe, any clinical deployment would still need evaluation under GDPR, institutional privacy policies, professional responsibility standards, and local healthcare regulations. HIPAA is simply not the relevant legal framework in Italy. GDPR and national rules are. ## ChatGPT Health: a different product for patients OpenAI has also introduced **ChatGPT Health**, which should not be confused with ChatGPT for Clinicians. ChatGPT Health is designed for patients and general users. The company describes it as a dedicated health and wellness experience where users may connect medical records and wellness apps, with additional privacy protections. Per OpenAI, the product is meant to help people understand their health information and prepare for conversations with clinicians, not to provide diagnosis or treatment. At launch, ChatGPT Health is available only to selected users. Not in the European Economic Area, Switzerland, or the United Kingdom. The same broader pattern, again. OpenAI’s healthcare ecosystem is developing quickly, but access remains constrained by geography and regulation. ## My access attempt from Italy As an Italian cardiac surgeon, I had an obvious interest in testing whether ChatGPT for Clinicians could be accessed from Italy. The idea of a clinician-oriented AI workspace, with clinical search, structured evidence review, reusable workflows, and stronger safeguards, is directly relevant to current medical practice. The limitation, as expected, surfaced before any real clinical testing could begin. OpenAI’s documentation states that the sign-up process requires a valid U.S. National Provider Identifier. Italian physicians do not normally have an NPI, so the current self-service access pathway cannot be completed by a physician practicing only in Italy. Calling this a technical failure would be inaccurate. It is a structural access limitation. The system is built around U.S. professional verification, not around international medical licensing frameworks. ## Step-by-step access check from Italy The practical access check is straightforward: 1. Visit the official ChatGPT for Clinicians page. 2. Sign in with a ChatGPT account. 3. Start the clinician verification process. 4. Check whether the system asks for a U.S. NPI. 5. Do not invent an NPI. Do not use another clinician’s identifier. 6. If the process requires an NPI, stop the attempt and document that the current pathway is not applicable to Italian physicians. 7. Do not upload patient data, clinical letters, reports, or identifiable medical information during the process. That last point is non-negotiable. Until there is a clear legal, contractual, and institutional framework in place, real patient data should not be used for experimental access attempts. ## What this means for European clinicians For now, European clinicians have three more realistic options. First, standard ChatGPT can be used for non-identifiable educational, scientific, and editorial work: literature summaries, teaching material, coding assistance, academic writing support, conceptual discussion. Second, prototypes can be built through the OpenAI API using anonymized, synthetic, or non-identifiable data. Particularly relevant for research workflows, medical education, RAG systems, ICD/DRG coding tools, and clinical documentation experiments. Third, institutions may explore ChatGPT for Healthcare as an enterprise route. Only after formal evaluation of privacy, governance, data processing agreements, GDPR compliance, clinical safety, and professional responsibility, however. ## Conclusion OpenAI’s healthcare products represent a meaningful step toward specialized AI tools for medicine. ChatGPT for Clinicians is particularly interesting because it acknowledges what clinical work actually is: not generic text generation, but a domain that requires evidence, citations, structured workflows, safety constraints, and professional accountability. The current access model, though, reveals a clear asymmetry. U.S. clinicians are the first target population. Physicians in Italy and other European countries remain outside the self-service pathway. Speaking as a clinician, I find the situation both promising and frustrating. Promising, because the direction is clearly the right one: medical [AI tools need dedicated environments](https://www.micheledpierri.com/wp-content/uploads/wp-mfa-exports/post/local-llms-clinical-data-privacy-eu.md). Frustrating, because international clinicians who are already engaging seriously with AI, research, documentation, and healthcare innovation cannot yet access the clinician-specific product through their own professional credentials. The crucial question is no longer whether AI will enter clinical practice. That question has already been answered. The real question is whether access to safe, verified, and professionally governed medical AI tools will expand beyond the U.S. in a way that respects the regulatory, ethical, and clinical realities of European healthcare systems. **LINKS** Official access page: [ChatGPT for Clinicians](https://chatgpt.com/plans/clinicians/) OpenAI Help Center page: [ChatGPT for Clinicians – Help Center](https://help.openai.com/en/articles/20001202-chatgpt-for-clinicians)